Action VLS VITA LIFE SCIENCES LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Vita Life Sciences Limited

Actions

VLS

AU000000VLS8

Marché Fermé - Australian S.E.
Autres places de cotation
 03:37:39 03/05/2024 		Varia. 5j. Varia. 1 janv.
2,26 AUD -0,44 % Graphique intraday de Vita Life Sciences Limited +0,89 % +26,97 %
26/02 Vita Life Sciences Limited publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Vita Life Sciences Limited donne des prévisions de résultats pour l'année complète se terminant le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Vita Life Sciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Vita Life Sciences Limited Provides Earnings Guidance for the Full Year Ending December 31, 2023
Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023
Vita Life Sciences Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Vita Life Sciences Limited Appoints Peter Osborne as an Independent Non-Executive Director
Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending 30 June 2023
Vita Life Sciences Limited announces an Equity Buyback for 8,475,692 shares, representing 15% of its issued share capital.
Vita Life Sciences Limited's Equity Buyback announced on May 11, 2022, has expired with 208,000 shares, representing 0.37% for AUD 0.34 million.
Vita Life Sciences Limited authorizes a Buyback Plan.
Vita Life Sciences Limited Announces Demise of Gregory Ralph, Non-Executive Director
Vita Life Sciences Limited Announces Dividend for Six Months Ended December 31, 2022, Payable on April 14, 2023
Vita Life Sciences Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Vita Life Sciences Provides Earnings Guidance for the Full Year Ending 31 December 2022
Vita Life Sciences Limited Announces Board Changes, Effective 30 September 2022
Vita Life Sciences Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022
Vita Life Sciences Expects Higher H1 Sales, Pretax Profit
Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2022
Vita Life Sciences Limited announces an Equity Buyback for 8,325,392 shares, representing 15% of its issued share capital.
Vita Life Sciences Limited's Equity Buyback announced on May 28, 2021, has expired.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action VLS
  4. Actualités Vita Life Sciences Limited
  5. Autres langues